These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 34439239)
21. Clinical Significance of Peripheral Blood PCA3 Gene Expression in Early Diagnosis of Prostate Cancer. Chunhua L; Zhao H; Zhao H; Lu Y; Wu J; Gao Z; Li G; Zhang Y; Wang K Transl Oncol; 2018 Jun; 11(3):628-632. PubMed ID: 29574327 [TBL] [Abstract][Full Text] [Related]
22. Predicting prostate biopsy outcome: prostate health index (phi) and prostate cancer antigen 3 (PCA3) are useful biomarkers. Ferro M; Bruzzese D; Perdonà S; Mazzarella C; Marino A; Sorrentino A; Di Carlo A; Autorino R; Di Lorenzo G; Buonerba C; Altieri V; Mariano A; Macchia V; Terracciano D Clin Chim Acta; 2012 Aug; 413(15-16):1274-8. PubMed ID: 22542564 [TBL] [Abstract][Full Text] [Related]
23. More advantages in detecting bone and soft tissue metastases from prostate cancer using Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003 [TBL] [Abstract][Full Text] [Related]
24. The Single-parameter, Structure-based IsoPSA Assay Demonstrates Improved Diagnostic Accuracy for Detection of Any Prostate Cancer and High-grade Prostate Cancer Compared to a Concentration-based Assay of Total Prostate-specific Antigen: A Preliminary Report. Klein EA; Chait A; Hafron JM; Kernen KM; Manickam K; Stephenson AJ; Wagner M; Zhu H; Kestranek A; Zaslavsky B; Stovsky M Eur Urol; 2017 Dec; 72(6):942-949. PubMed ID: 28396176 [TBL] [Abstract][Full Text] [Related]
25. Comparative assessment of urinary prostate cancer antigen 3 and TMPRSS2:ERG gene fusion with the serum [-2]proprostate-specific antigen-based prostate health index for detection of prostate cancer. Stephan C; Jung K; Semjonow A; Schulze-Forster K; Cammann H; Hu X; Meyer HA; Bögemann M; Miller K; Friedersdorff F Clin Chem; 2013 Jan; 59(1):280-8. PubMed ID: 23213079 [TBL] [Abstract][Full Text] [Related]
26. High PCA3 scores in urine correlate with poor-prognosis factors in prostate cancer patients. Wei W; Leng J; Shao H; Wang W Int J Clin Exp Med; 2015; 8(9):16606-12. PubMed ID: 26629191 [TBL] [Abstract][Full Text] [Related]
27. Clinical utility of the PCA3 urine assay in European men scheduled for repeat biopsy. Haese A; de la Taille A; van Poppel H; Marberger M; Stenzl A; Mulders PF; Huland H; Abbou CC; Remzi M; Tinzl M; Feyerabend S; Stillebroer AB; van Gils MP; Schalken JA Eur Urol; 2008 Nov; 54(5):1081-8. PubMed ID: 18602209 [TBL] [Abstract][Full Text] [Related]
29. [The value of PHI/PCA3 in the early diagnosis of prostate cancer]. Tan SJ; Xu LW; Xu Z; Wu JP; Liang K; Jia RP Zhonghua Yi Xue Za Zhi; 2016 Jan; 96(2):100-3. PubMed ID: 26792690 [TBL] [Abstract][Full Text] [Related]
30. PCA3 molecular urine assay for prostate cancer in men undergoing repeat biopsy. Marks LS; Fradet Y; Deras IL; Blase A; Mathis J; Aubin SM; Cancio AT; Desaulniers M; Ellis WJ; Rittenhouse H; Groskopf J Urology; 2007 Mar; 69(3):532-5. PubMed ID: 17382159 [TBL] [Abstract][Full Text] [Related]
31. PSGR and PCA3 as biomarkers for the detection of prostate cancer in urine. Rigau M; Morote J; Mir MC; Ballesteros C; Ortega I; Sanchez A; Colás E; Garcia M; Ruiz A; Abal M; Planas J; Reventós J; Doll A Prostate; 2010 Dec; 70(16):1760-7. PubMed ID: 20672322 [TBL] [Abstract][Full Text] [Related]
32. Urinary miR-183 and miR-205 do not surpass PCA3 in urine as predictive markers for prostate biopsy outcome despite their highly dysregulated expression in prostate cancer tissue. Stephan C; Jung M; Rabenhorst S; Kilic E; Jung K Clin Chem Lab Med; 2015 Jun; 53(7):1109-18. PubMed ID: 25720086 [TBL] [Abstract][Full Text] [Related]
33. Urine TMPRSS2:ERG fusion transcript integrated with PCA3 score, genotyping, and biological features are correlated to the results of prostatic biopsies in men at risk of prostate cancer. Cornu JN; Cancel-Tassin G; Egrot C; Gaffory C; Haab F; Cussenot O Prostate; 2013 Feb; 73(3):242-9. PubMed ID: 22821767 [TBL] [Abstract][Full Text] [Related]
34. Urinary Prostate Cancer Antigen 3 as a Tumour Marker: Biochemical and Clinical Aspects. Schmid M; Hansen J; Chun FK Adv Exp Med Biol; 2015; 867():277-89. PubMed ID: 26530372 [TBL] [Abstract][Full Text] [Related]
35. Combining Prostate Health Index density, magnetic resonance imaging and prior negative biopsy status to improve the detection of clinically significant prostate cancer. Druskin SC; Tosoian JJ; Young A; Collica S; Srivastava A; Ghabili K; Macura KJ; Carter HB; Partin AW; Sokoll LJ; Ross AE; Pavlovich CP BJU Int; 2018 Apr; 121(4):619-626. PubMed ID: 29232037 [TBL] [Abstract][Full Text] [Related]
36. Long non-coding RNA metastasis associated in lung adenocarcinoma transcript 1 derived miniRNA as a novel plasma-based biomarker for diagnosing prostate cancer. Ren S; Wang F; Shen J; Sun Y; Xu W; Lu J; Wei M; Xu C; Wu C; Zhang Z; Gao X; Liu Z; Hou J; Huang J; Sun Y Eur J Cancer; 2013 Sep; 49(13):2949-59. PubMed ID: 23726266 [TBL] [Abstract][Full Text] [Related]
37. Optimizing prostate cancer screening; prospective randomized controlled study of the role of PSA and PCA3 testing in a sequential manner in an opportunistic screening program. Rubio-Briones J; Casanova J; Dumont R; Rubio L; Fernandez-Serra A; Casanova-Salas I; Domínguez-Escrig J; Ramírez-Backhaus M; Collado A; Gómez-Ferrer A; Iborra I; Monrós JL; Ricós JV; Solsona E; Salas D; Martínez F; Lopez-Guerrero JA Actas Urol Esp; 2014 May; 38(4):217-23. PubMed ID: 24169211 [TBL] [Abstract][Full Text] [Related]
38. Multiparametric magnetic resonance imaging of the prostate can improve the predictive value of the urinary prostate cancer antigen 3 test in patients with elevated prostate-specific antigen levels and a previous negative biopsy. Sciarra A; Panebianco V; Cattarino S; Busetto GM; De Berardinis E; Ciccariello M; Gentile V; Salciccia S BJU Int; 2012 Dec; 110(11):1661-5. PubMed ID: 22564540 [TBL] [Abstract][Full Text] [Related]
39. Improving the prediction of pathologic outcomes in patients undergoing radical prostatectomy: the value of prostate cancer antigen 3 (PCA3), prostate health index (phi) and sarcosine. Ferro M; Lucarelli G; Bruzzese D; Perdonà S; Mazzarella C; Perruolo G; Marino A; Cosimato V; Giorgio E; Tagliamonte V; Bottero D; De Cobelli O; Terracciano D Anticancer Res; 2015 Feb; 35(2):1017-23. PubMed ID: 25667489 [TBL] [Abstract][Full Text] [Related]
40. Real-time PCR PCA3 assay is a useful test measured in urine to improve prostate cancer detection. Foj L; Milà M; Mengual L; Luque P; Alcaraz A; Jiménez W; Filella X Clin Chim Acta; 2014 Aug; 435():53-8. PubMed ID: 24803095 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]